Drug factory · FDA FEI 3004096632

Moehs Cantabra SL

Poligono Industrial Requejada, S/N, Polanco, Spain

Spain: 1

Problems found, fixed voluntarily at FDA's last inspection, Jul 17, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

6 drug inspections on record since 2010: 0 with no problems, 5 with problems fixed voluntarily, 1 with FDA action.

What it does, for whom

DrugRoleForNDC
VenlafaxineMakes the active ingredient IntelliPharmaCeutics Corp. 35208-011, 35208-012, 35208-013

FDA inspection history

EndedResultProgramProblems noted
Jul 17, 2025Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 24, 2022Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 18, 2018Problems found, fixed voluntarilyDrug Quality Assurance—
Oct 9, 2015Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 30, 2012Problems found, fixed voluntarilyDrug Quality Assurance—
Dec 17, 2010Serious problems, FDA actionDrug Quality Assurance—

Registered with FDA for: api manufacture.